Aptahem AB
Biotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Oversigt
- 0
- Medarbejdere
- -1 SEK
- Omsætning
- 2014
- Grundlagt
Nøglebeslutningstagere
Mikael Lindstam
CEO
Beskrivelse
Aptahem is a specialized biotechnology company focused on developing novel RNA-based pharmaceuticals. Their primary mission is to create disruptive treatments for acute, life-threatening inflammatory diseases, such as sepsis. The company's lead drug candidate, Apta-1, is currently progressing throug...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556970578201
Beslutningstagere
1 kontakter i FunnelfeedrMikael Lindstam
CEO
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Oblique Therapeutics AB (publ)
10–19 medarbejdereInnovative biotech developing breakthrough antibodies using the AbiProt platform.
Modus Therapeutics Holding AB
1–4 medarbejdereSwedish biotech developing sevuparin for severe inflammatory conditions.
Sangair AB
3 medarbejdereDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Ribocure Pharmaceuticals AB
20–49 medarbejdereClinical stage biotech developing cutting-edge RNA therapeutics for rare diseases.
IONLACE AB
9 medarbejdereRewriting medicine timelines using AI and modular protein design.
Udforsk mere
Spørgsmål om Aptahem AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo